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Abstract
Background: Malaria is the most important imported tropical disease. Infection with Plasmodium falciparum is
responsible for most of the morbidity and mortality. There are differences in both the epidemiology of imported
malaria and in the facilities available to treat travellers with severe malaria between different parts of the world.
There are limited data to guide clinicians caring for adults with imported malaria in an intensive care unit (ICU).
Available data from the English-speaking literature concerning such patients was reviewed.
Methods: PubMed was searched for studies on adults with imported malaria treated in an ICU. Data were extracted
on the epidemiology, management, rates of concomitant community-acquired bacterial infection and outcomes.
Results: Thirteen studies were identified, which between them included 1,001 patients over more than 40 years.
Forty-one per cent were born and often still resident in an endemic country and were assumed to have at least partial
immunity to the disease. Acute kidney injury (AKI) (36%), acute respiratory distress syndrome (ARDS) (31%) and impaired
consciousness (25%) were common. Hyperparasitaemia (more than 2%) was seen in 57%. Thirty-four per cent required
mechanical ventilation and 22% required renal replacement therapy. Community-acquired bacterial co-infection was
seen in 8%; 2% had gram-negative bacteraemia at admission. Overall the case fatality rate was 9%.
Conclusions: Many patients who require admission to ICU were originally from malaria-endemic countries and many
did not have hyperparasitaemia. Gram-negative bacteraemia was uncommon among adults with severe malaria. The
case fatality rate remains high; however, improvements in ICU care and increasing use of artemisinins may reduce this
in the future.
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Background
Malaria is the most important imported tropical disease
and responsible for most deaths that occur among indi-
viduals returning from the tropics. Plasmodium falcip-
arum is responsible for virtually all cases of imported
malaria that require admission to an intensive care unit
(ICU), including those that die, which may be as many
as 29% [1].
Most descriptions of the clinical spectrum of severe
malaria disease come from countries where the disease
is endemic and predominantly affects young children. In
these settings, adults are assumed to develop some de-
gree of immunity to the disease, although this is rapidly
lost if they move away from an endemic area [2]. The
precise mechanisms that contribute to this acquired im-
munity remain poorly understood [2] and there is no
agreed definition of ‘immunity’ in studies of imported
malaria. Relatively few data have been published con-
cerning the pattern of disease among adult patients with
severe imported malaria. The aim of this study was to
review all published series of falciparum malaria requir-
ing admission to an ICU in resource-rich countries to
determine the reasons for admission, complication and
case fatality rates and the frequency of concomitant bac-
terial sepsis, which has been reported to be very high
among African children with the disease [3].
Methods
Search method
PubMed was searched for any papers published. Combi-
nations of the following search terms were used: “malaria”,
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“falciparum”, “ITU”, “ICU”, “intensive care”, “imported”
and “non-endemic”. The abstracts of all these papers were
reviewed for eligibility by MM. The bibliographies of eli-
gible articles were screened to identify any other relevant
publications.
Study selection
Papers were included only if they reported data on the
care and outcome of adult (aged ≥18 years) patients with
imported malaria requiring admission to ICU. For prag-
matic reasons case series of fewer than ten patients were
excluded.
Data extraction
Data from each paper were extracted on to a stan-
dardized form. Where possible, data were recorded about
demographics, region of travel, use of anti-malarial chemo-
prophylaxis, the management of malaria, including re-
quirements for organ support, complications of malaria,
rates and nature of bacterial co-infection and outcome.
Statistical analyses
Continuous variables were described with mean and
standard deviation (SD) or with median and interquartile
range (IQR) as appropriate. Categorical data were described
with numbers and per cent. All analyses were carried out
using Stata 10 (Statacorp).
Results
Literature search
The literature search identified 61 papers, 13 of which
were included (Figure 1) [1,4-15]. Forty-eight were ex-
cluded; 22 were not published in English, 11 were not
primary research articles, four reported only on paediatric
cases and 11 were short case series that included fewer
than ten patients. The 13 studies reviewed included a total
of 1,001 patients over a 41-year period (Table 1). All 13
were retrospective cohort studies; 11 reported patients
treated in Europe; the other two were from Singapore and
South Africa. Four studies included some patients with se-
vere malaria that were not admitted to an ICU and seven
included some aged under 18 years (n = 15 in total); where
possible, individual patient data were used to exclude
these from further analyses. Where it was not possible to
exclude paediatric patients from the analysis, this is made
that clear.
Epidemiology
Of the 1,001 patients, men aged between 30 and 50 made
up the largest group (Table 2). In studies in which ethnicity
was reported (nine studies, 916 patients), most were origin-
ally from non-endemic countries (59%, range 49-100%).
Except for the paper from Singapore [9], P. falciparum was
almost always acquired during travel to sub-Saharan Africa.
Use of appropriate anti-malarial chemoprophylaxis was
poor (<20%) in all studies.
The definition of “immunity” to malaria varied between
studies (Additional file 1). Individual patient data was not
available to allow a consistent definition of immunity to
be applied across all studies.
Treatment of malaria and ICU care
Quinine was the usual first-line drug in all 13 studies
(Table 3). Use of artemisinins was reported in only one
paper [10]. In the study by Nüesch [11], chloroquine with
or without sulphadoxine/pyrimethamine was the first-line
Figure 1 Search strategy.
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anti-malarial treatment before 1987. In those studies lim-
ited exclusively to patients admitted to ICU, the propor-
tion of patients requiring renal replacement therapy,
mechanical ventilation and inotropic support were 22%
(95% CI 19-25%), 34% (95% CI 32-38%) and 27% (95% CI
24-30%), respectively. Only two small studies (n = 52)
provided adequate detail to assess requirements of indi-
vidual patients for multiple organ support. In these two
studies 44% of patients required at least two organ sup-
port. Six studies reported the use of exchange transfusion
in a median of 25% of patients (IQR 18-29%). The median
length of stay on ICU ranged from –four to 11 days.
Table 1 Included studies
Study Country Time period Study type Number of patients
Badiaga [4] France 1996-2002 Single centre 37a
Blumberg [1] South Africa 1993-1994 Single centre 23b
Bruneel 2003 [5] France 1988-1999 Single centre 188
Bruneel 2010 [6] France 2000-2006 Multi centre (n = 45) 400
Gachot [7] France 1988-1993 Single centre 40
Gonzalez [8] Spain 1991-2007 Single centre 20c
Khoo [9] Singapore 1994-1997 Single centre 19d
Marks [10] United Kingdom 1994-2010 Single centre 124
Nüesch [11] Switzerland 1970-1992 Multi centre (n = 2) 23
Salord [12] France 1985-1990 Single centre 19e
Santos [13] Spain 1990-2011 Single centre 56f
Schwake [14] Germany 1996-2003 Single centre 13
Thierfelder [15] Switzerland 1994-2004 Single centre 38g
aTwo paediatric cases excluded.
bFive paediatric cases excluded where possible.
cAt least one patient was aged under 18.
dOne paediatric case excluded.
eTwo paediatric cases excluded from further analyses where possible.
fThree paediatric cases excluded from further analyses where possible.
gAt least one patient was aged under 18 and one patient had Vivax infection: Individual patient data were not available therefore these patients could not be
excluded from further analyses.
Table 2 Demographics and epidemiology
Study Male Median age (Median + IQR, or Mean ± SD) Semi immunea Acquired in Africa Adequate chemoprophylaxis
Badiaga 73% 45 (IQR 29-55) 17% 100% 5%
Blumberg 61% 38 (IQR 30-48 · 5) Not reported 100% Not reported
Bruneel 2003 [5] 63% 38 (no IQR available, range 14-74), 49% 94% 4%
Bruneel 2010 [6] 70% 42 · 8 ± 15b + 55 · 6 ± 14 · 2c 40% 96% 16%
Gachot 58% 39 · 2 ± 3 · 7d + 38 · 3 ± 0 · 2e 35% 95% Not reported
Gonzalez 75% 44 (No IQR available, range 16-68) 0% 95% 0%
Khoo 89% 38 (IQR 29 · 5 – 50 · 5) Not reported 21% 0%
Marks 63% 46 (IQR 35-55) 45% 94% 1%
Nüesch 83% 42 (IQR 37 · 5-51) Not reported Not reported 9%
Salord 74% 37 (IQR 28 · 5-42 · 5) Not reported 95% 0%
Santos 80% 42 (IQR 33-50) 51% 95% 2%
Schwake 72% 38 · 4 ± 11 · 4f 28% 88% 20%
Thierfelder 50% 38 (no IQR available, range 16-71)g 49% 82% Not reported
aDefinitions of Semi-Immune provided in Additional file 1.
bSurvivors cNon-Survivors.
dPatients with Acute Lung Injury ePatients without Acute Lung Injury.
fNot all patients in the study were admitted to ICU - Demographic data for only those patients admitted to ICU was not available.
gNot all patients in the study were admitted to ICU - Demographic data for only those patients admitted to ICU was not available. Individual patient data were
not available therefore it was not possible to exclude the paediatric cases from these figures.
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Table 3 Management of patients
Study Quinine Artemisinins Renal replacement therapy Invasive ventilation Inotropic support Exchange transfusion Length of ICU admission
(Median days, IQR)
Badiaga 100% 0% Not reported Not reported Not reported Not reported 4 (2-14)
Blumberg 100% 0% 48% 57% 57% 17% 8 (5-13)
Bruneel 2003 [5] 100% 0% 15% 43% 13% 0% 8 (4-13) 2 (1-4)
Bruneel 2010 [6] 98% Not reported 20% 29% 27% 0% 4 (2-7) 5 (3-8)
Gachot 100% 0% Not reported 23% Not reported Not reported 11 (No IQR available)
Gonzalez 100% 0% 40% 50% Not reported 30% 5 (3-12)
Khoo 100% 0% 47% 42% 37% 32% 5 +/- 4(Mean)
Marks 99% 17% 35% 37% 35% 27% 10 (7-9)
Nüesch 15% (Pre-1987) 100% (1987-) 0% 9% 26% 22% 22% 6 (2-28)
Salord 89% 0% 5% 42% 11% 16% Not reported
Santos 100% 0% 14% 37% 49% Not reported 4 (2-12) 8 (3-27)
Schwake 100% 0% 7% 5% 8% Not reported 5 (3-6)
Thierfelder Not reported Not reported Not reported Not reported Not reported Not reported Not reported
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Bacterial co-infections
The rate of community-acquired bacterial co-infection was
reported in seven studies (n = 855, including four paediatric
cases) with an overall prevalence of 8% (n = 66; range
0-13%). Pneumonia was the most common community-
acquired co-infection occurring in 28 (3%) cases. Bacter-
aemia, defined as a positive blood culture within 48 hours
of admission, was found in 25 (3%) cases; most of these
(18, (72%)) were caused by gram-negative bacteria.
Complications of Plasmodium falciparum infection
Definitions of complications, including hyperparasitaemia,
varied between studies (Additional file 2). The frequency
with which these complications occurred is shown in
Table 4.
Ten studies (n = 918, including 14 paediatric cases) re-
ported the presence of hyperparasitaemia, which was
seen in 523 (57%) patients, using a cut-off of 2% (95% CI
54-60%). When only studies using a cut-off of >5% were
analysed, the prevalence of hyperparasitaemia was 44%
(95% CI 39-49%).
Twelve studies (n = 971, including 14 paediatric cases)
reported the presence of AKI, which was seen in 350 pa-
tients (36%) (95% CI 33-39%). The proportion of patients
with acute kidney injury (AKI) did not differ signifi-
cantly between studies that defined this as both oli-
guria and elevated creatinine and those studies that
used only an elevated creatinine (40 vs 34%, p = 0 · 1280)
to define AKI.
Twelve studies (n = 971, including 14 paediatric cases)
reported the presence of acute respiratory distress syn-
drome (ARDS), which was seen in 301 patients (31%; 95%
CI 28-34%). Two studies (n = 161) [6,10] reported both
complications at admission and complications that de-
veloped during the ICU stay; ARDS was present at ad-
mission in three (2%) and developed later in a further
32 (20%).
Ten studies (n = 952, including 12 paediatric cases) re-
ported the presence of impaired consciousness, used as
a proxy for cerebral malaria, which was seen in 238 pa-
tients overall (25%; 95% CI 22-28%).
Five studies (n = 624) reported the total number of com-
plications that occurred per patient. The mean number of
complications seen was 2.86% (95% CI 2.81-2.91%). Indi-
vidual patient data was not available to assess if particular
combinations of complications occurred with an increased
frequency.
WHO defines severe malaria using a range of other cri-
teria that include: acidosis, coagulopathy, hypoglycaemia,
jaundice, and anaemia. The rates of these complications,
where available, are shown in Table 4.
Case fatality rates were reported in all 13 studies. The
overall case fatality rate was 9% (95% CI 8-11%) but a case
fatality rate of over 15% was reported in four studies.
Conclusions
This is the first review of imported falciparum malaria
among adults who were sufficiently unwell to require ad-
mission to ICU. The review supports four important
conclusions. First, hyperparasitaemia, however this is de-
fined, is not a feature in almost 50% of patients; second,
up to 40% of these patients were originally from or still
resident in a malaria-endemic region and may therefore
be assumed to have at least partial immunity to the dis-
ease; third, co-infection with community-acquired gram-
negative bacteraemia is uncommon among adults; and,
finally, the case fatality rate for severe imported malaria
in ICU is in the region of 10%.
AKI, ARDS and cerebral malaria were all common. Inva-
sive ventilation was required in 22% and renal replacement
therapy was required in approximately 22%. Hyperparasi-
taemia, which is often used as a proxy for severe falciparum,
was seen in only 57% of subjects when a cut-off of ≥2% was
used. When using a definition of ≥5% parasitaemia, which
the WHO recommends as the criterion for severe disease
in endemic areas, this proportion fell to 44%. Clinicians
would be well advised not to rely on parasite count as the
only indicator of severe disease.
Gram-negative bacteraemia, classically with non-typhoi
dal Salmonellae, is a well recognized complication of mal-
aria in children [3], occurring in up to 20%. Recent studies
have suggested that dysfunctional granulocyte mobiliza
tion may be responsible for this [16]. While 8% of pa-
tients had a presumed community-acquired bacterial
co-infection, usually pneumonia, at admission, only 25
(3%) had culture-positive, gram-negative bacteraemia.
Previous prescription of antibiotics may have caused
some bias and a lower yield but it is possible that this
reflects a difference in the pathophysiology of severe
malaria in adults compared to children.
The overall case-fatality rate was 9% although one study
[1] reported a rate as high as 29%. Quinine was the most
commonly used anti-malarial agent in all 13 studies. Arte-
sunate has been shown to significantly reduce case fatality
from severe malaria in both Southeast Asia and Africa
[17,18]. Only one of these studies [10] included patients
treated with artemisinins, but as these drugs become more
widely available the case fatality from severe imported
malaria may decline.
This review has several weaknesses. A number of studies
that were not published in English were excluded and it is
possible that this may have had an effect. Most of the in-
cluded studies were from Europe and the conclusions may
not be relevant to other settings where imported malaria
is seen. In particular, indications for ICU admission are
likely to have varied both between the study sites and over
the period that the studies were conducted, which may
partially explain the spectrum of disease severity and out-
comes seen. Individual patient data were often unavailable,
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Table 4 Complications
Study Hyper-
Parasitaemia
Acidosis AKI Impaired
consciousness
Shock Coagulopathy ARDS Hypoglycaemia Jaundice Seizures Anaemia Haema
globinuria
Bacterial
Co-Infection
Mortality
Badiaga 78% 8% 35% 24% 19% 8% 24% 0% 62% 11% 0% 14% Not
reported
8%
Blumberg 79% 36% 61% 39% 46% 14% 46% 11% 39% 11% 21% 0% Not
reported
29%
Bruneel
2003 [5]
21% 10% 25% 18% 11% 12% 5% 2% 27% 1% 8% 1% 10% 5%
Bruneel
2010 [6]
64% 18% 34% 26% 24% 3% 25% 3% 52% 7% 4% 6% 8% 11%
Gachot Not
reported
Not
reported
55% 38% 25% 35% 30% 10% Not
reported
Not
reported
8% Not
reported
13% 13%
Gonzalez 60% 30% 35% 20% 25% 55% 10% 15% 90% 10% 0% 5% 0% 25%
Khoo 45% 35% 45% 0% 30% 30% 5% 0% 75% 15% 20% Not
reported
Not
reported
15%
Marks 66% 55% 44% 35% 27% 11% 19% 4% 69% 7% 4% 0% 5% 4%
Nüesch 65% Not
reported
26% 17% 9% 4% 4% Not
reported
4% Not
reported
13% Not
reported
13% 17%
Salord 58% Not
reported
32% 47% Not
reported
Not
reported
26% Not
reported
42% 16% Not
reported
Not
reported
Not
reported
0%
Santos 78% 39% 53% 19% 49% 22% 37% 31% 46% Not
reported
0% Not
reported
3% 15%
Schwake Not
reported
31% 38% 23% 38% 31% 15% 23% Not
reported
0% 0% Not
reported
Not
reported
0%
Thierfelder Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
0%
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which meant paediatric cases could not reliably be ex-
cluded, although there were only 15 of these. For the same
reasons, it was not possible to analyse temporal trends in
case fatality rates or perform a detailed meta-analysis of
risk factors associated with mortality. However, the review
includes all series of more than ten patients published in
English over more than 40 years and provides important
insights into the management of this relatively uncommon
disease.
It is noteworthy that no case series from North America
were included in the current paper. In 2011 the United
States reported 1,925 cases of America of which 183 were
reported to have severe disease [19]. Given the significantly
larger population of the United States, compared to the
other countries represented in this paper, it is possible that
no American centre sees a sufficiently large enough num-
ber of cases to inform a study of severe malaria in the USA.
The overall case fatality rate of 9% may not reflect
modern practice. Management of ARDS has improved
considerably in recent years and newer strategies for fluid
resuscitation, in particular, may reduce the incidence of
both multi-organ failure and long-term disability [20].
Similarly, optimizing fluid management for patients with
ARDS may reduce pulmonary capillary leak and subse-
quently the length of time that patients require on ICU
[21]. Greater awareness of what constitutes AKI [22] may
also result in a better outcome. Each of these factors, as
well as improved antimicrobial protocols, management of
shock and acidosis and increasing use of artemisinins,
may further reduce the case fatality associated with severe
imported malaria in the future.
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